News &

Press

venBio news

“venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences.”

“venBio Closes $394 Million Life Sciences Venture Capital Fund.”

Portfolio news

Introducing Fierce Biotech’s 2023 Fierce 15 – FOG and RayzeBio

Aug 28, 2023

Artiva Biotherapeutics Announces FDA Clearance of IND for AlloNK® Cell Therapy Candidate in Combination with Rituximab in Lupus Nephritis

Aug 16, 2023

ImmPACT Bio Announces FDA Clearance of IND Application

Aug 15, 2023

Attovia Therapeutics Launches with $60 Million Series A Financing to Unlock Potential of Novel Biparatopic Nanobody Platform

Jun 20, 2023

Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer

Apr 20, 2023

Abdera skyrockets out of stealth with $142M as radiopharmaceutical ambitions take flight

Apr 20, 2023

Entact Bio’s CEO is leading the company out of stealth and into a new age of protein enhancement

Feb 27, 2023

San Francisco office

1700 Owens Street, Suite 595
San Francisco, CA 94158

Seattle office

1200 Westlake Ave N, Suite 900
Seattle, WA 98109

© 2023 venBio. All Rights Reserved.